相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。New Frontiers in the Treatment of Type 1 Diabetes
Jeremy T. Warshauer et al.
CELL METABOLISM (2020)
Properties of FDA-approved small molecule protein kinase inhibitors: A 2020 update
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2020)
TH1 cell-inducingEscherichia colistrain identified from the small intestinal mucosa of patients with Crohn's disease
Manabu Nagayama et al.
GUT MICROBES (2020)
STAT1 Gain of Function, Type 1 Diabetes, and Reversal with JAK Inhibition
Natalia S. Chaimowitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Inducing and exploiting vulnerabilities for the treatment of liver cancer
Cun Wang et al.
NATURE (2019)
Type 1 Diabetes in STAT Protein Family Mutations: Regulating the Th17/Treg Equilibrium and Beyond
Marco Fabbri et al.
DIABETES (2019)
Stem Cell Therapies for Treating Diabetes: Progress and Remaining Challenges
Julie B. Sneddon et al.
CELL STEM CELL (2018)
Kinase inhibitors: the road ahead
Fleur M. Ferguson et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Repurposed JAK1/JAK2 Inhibitor Reverses Established Autoimmune Insulitis in NOD Mice
Prerak M. Trivedi et al.
DIABETES (2017)
Toxic Effects of Sorafenib in Patients With Differentiated Thyroid Carcinoma Compared With Other Cancers
Gary W. Jean et al.
JAMA ONCOLOGY (2016)
Interleukin-12: Functional activities and implications for disease
Sebastian Zundler et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2015)
Thinking bedside at the bench: the NOD mouse model of T1DM
James C. Reed et al.
NATURE REVIEWS ENDOCRINOLOGY (2015)
Insulin secretion in patients with latent autoimmune diabetes (LADA): half way between type 1 and type 2 diabetes: action LADA 9
Marta Hernandez et al.
BMC ENDOCRINE DISORDERS (2015)
High GADA titer increases the risk of insulin requirement in LADA patients: a 7-year follow-up (NIRAD study 7)
Simona Zampetti et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2014)
Human and Mouse VEGFA-Amplified Hepatocellular Carcinomas Are Highly Sensitive to Sorafenib Treatment
Elad Horwitz et al.
CANCER DISCOVERY (2014)
Severe Hypoglycemia Due to Possible Interaction Between Glibenclamide and Sorafenib in a Patient with Hepatocellular Carcinoma
Andreas Holstein et al.
CURRENT DRUG SAFETY (2013)
Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients
Ken T. Coppieters et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Type 1 Diabetes: Etiology, Immunology, and Therapeutic Strategies
Tom L. Van Belle et al.
PHYSIOLOGICAL REVIEWS (2011)
Effect of the tyrosine kinase inhibitors (sunitinib, sorafenib, dasatinib, and imatinib) on blood glucose levels in diabetic and nondiabetic patients in general clinical practice
Nicole M Agostino et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2010)
Analysis of islet inflammation in human type 1 diabetes
A. Willcox et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
T-bet-Deficient NOD Mice Are Protected from Diabetes Due to Defects in Both T Cell and Innate Immune System Function
Jonathan H. Esensten et al.
JOURNAL OF IMMUNOLOGY (2009)
Cytokine-secreting follicular T cells shape the antibody repertoire
R. Lee Reinhardt et al.
NATURE IMMUNOLOGY (2009)
Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes
William Duckworth et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
Anushka Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Effects of intensive glucose lowering in type 2 diabetes
Hertzel C. Gerstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Tyrosine kinase inhibitors reverse type 1 diabetes in nonobese diabetic mice
Cedric Louvet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Association of immune mediators at diagnosis of Type 1 diabetes with later clinical remission
N. C. Schloot et al.
DIABETIC MEDICINE (2007)
Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus
Julio C. Voltarelli et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Effects of autoimmunity and immune therapy on β-cell turnover in type 1 diabetes
Nicole A. Sherry et al.
DIABETES (2006)
Cyclophosphamide-induced type-1 diabetes in the NOD mouse is associated with a reduction of CD4+CD25+Foxp3+ regulatory T cells
Sven Brode et al.
JOURNAL OF IMMUNOLOGY (2006)
Discovery and development of sorafenib: a multikinase inhibitor for treating cancer
Scott Wilhelm et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Association of interferon-γ and interleukin 10 genotypes and serum levels with partial clinical remission in type 1 diabetes
B. Z. Alizadeh et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2006)
Immunological mechanisms associated with tong-term remission of human type 1 diabetes
Beate Karges et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2006)
Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4
WT Watford et al.
IMMUNOLOGICAL REVIEWS (2004)
IgG4-subclass of glutamic acid decarboxylase antibody is more frequent in latent autolmmune diabetes in adults than in type 1 diabetes
M Hillman et al.
DIABETOLOGIA (2004)
Autoimmune diabetes is blocked in stat4-deficient mice
ZD Yang et al.
JOURNAL OF AUTOIMMUNITY (2004)
Protein kinase inhibitors as a therapeutic modality
A Levitzki
ACCOUNTS OF CHEMICAL RESEARCH (2003)
The protein kinase complement of the human genome
G Manning et al.
SCIENCE (2002)
IL-12 plays a pathologic role at the inflammatory loci in the development of diabetes in NOD mice
Y Nitta et al.
JOURNAL OF AUTOIMMUNITY (2001)
Linkage disequilibrium of a type 1 diabetes susceptibility locus with a regulatory IL12B allele
G Morahan et al.
NATURE GENETICS (2001)
Partial impairment of cytokine responses in Tyk2-deficient mice
M Karaghiosoff et al.
IMMUNITY (2000)
Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.
AMJ Shapiro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
